301 followers
AdisInsight Report on #Fedtratinib (#INREBIC®) now online @drugsjournal https://t.co/5aRIgx96Si First approval in the USA for the treatment of intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) #myel